A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.

NCT01995383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

OTHER: LS followed by NS diet condition
OTHER: NS followed by LS diet condition
DRUG: Placebo
DRUG: Placebo
DRUG: RO6836191
DRUG: RO6836191
DRUG: RO6836191

Sponsor

Hoffmann-La Roche